Jonas Salk Net Worth: Jonas Salk was an American virologist and medical researcher who had a net worth of $ 3 million at the time of his death. He was best known for developing one of the first successful polo vaccines. The vaccine made him an American hero but, as we explain later, it did not make him a fortune. Today he is known as the “father of bio-philosophy”. He was Dr. Anthony Fauci of his time.

Jonas Salk was born in New York, New York in October 1914. He graduated from the New York University School of Medicine and chose to focus on medical research. He spent several years studying influenza viruses at the University of Michigan with his mentor Thomas Francis Jr. His field trial set up to test his polio vaccine was the most elaborate program of its kind in the story. Salk’s work combined the research of doctors around the world and ultimately produced the first effective vaccine against childhood paralysis.

He founded the Salk Institute for Biological Studies in La Jolla, California. Salk then focused on finding an HIV vaccine. His personal papers are kept at the Geisel Library at the University of California at San Diego. He married twice, including Françoise Gilot, one of Pablo Picasso’s former mistresses.

Jonas Salk died on June 23, 1995 at the age of 80.

Jonas Salk Net Worth

(Photo by Keystone Features / Getty Images)

Vaccine: Salk’s work has been built on the shoulders of many scientists and physicians around the world. For example, in 1954, two Harvard doctors found a safe and effective way to grow the virus on leftover tissue without contaminating themselves. This technique, on which Salk relied, would win the 1954 Nobel Prize to Harvard doctors.

There are basically two large-scale polio vaccines. Salk’s vaccine used a sample of ‘killed virus’ injected intravenously. Albert Sabin created a sample of “live virus” which was taken orally. Salk’s vaccine was arguably more effective, but it was more difficult to take and patients could still transmit the virus. Sabin’s vaccine was easier to take, especially for children, and killed the virus in the gut for good for that person. Sabin’s vaccine could also be stored indefinitely.

The oral / Sabin version is the most widely used vaccine in the world today because it is easier to administer and less expensive to produce. Since the 1990s, children in the United States have mainly received the Salk version because it poses a lower risk because it uses a killed virus.

Salk tested his vaccine on chimpanzees throughout 1952. He then tested it on about 80 children and staff at a medical home for disabled children in Pittsburgh.

Salk’s vaccine was tested on 1 million children before it was approved and licensed for public use (free) on April 12, 1955. About 10 million children had received the vaccine by the end of 1955. By the end of 1955. end of 1956, 30 million. Over the next few decades, the world would be almost completely eradicated from polio. In 1952, approximately 60,000 infants had infantile paralysis. In 1962, there were less than 1,000.

Lost fortune: Fortunately for mankind but perhaps unfortunately for the heirs of Sabin and Salk, the two doctors chose NOT to patent their work. They had the capacity to do this, but they actively decided to donate their work for free. If they had chosen to patent their work and charge even a modest royalty, Salk and Sabin would have made BILLIONS. It is estimated that Salk would have earned around $ 10 billion in his lifetime. Sabin is said to have earned more than $ 20 billion. Salk did not generate any significant wealth for himself from his vaccine.

Read more: Jonas Salk Net Worth

Related Posts